<DOC>
	<DOCNO>NCT01006863</DOCNO>
	<brief_summary>The prophylactic use small dos ephedrine may effective obtund hypotension response propofol minimal hemodynamic ST segment change . The investigator aim evaluate effect small dos ephedrine hemodynamic response propofol anesthesia valve surgery . There widespread interest use propofol induction maintenance anesthesia fast track cardiac surgery . However , use induction anesthesia often associate significant rate relate transient hypotension 5-10 minute . This mainly mediated decrease sympathetic activity minor contribution direct vascular smooth muscle relaxation direct negative inotropic effect . Ephedrine demonstrate vasopressor drug treatment hypotension association spinal general anesthesia . Prophylactic use high dos ephedrine [ 10-30 mg ] effective obtund hypotensive response propofol associate marked tachycardia . However , use small dos ( 0.1-0.2 mg/kg ) successfully attenuate , abolish , decrease blood pressure transient increase heart rate . This vasopressor effect mostly mediate β-stimulation rather α-stimulation also indirectly release endogenous norepinephrine sympathetic nerve . Because effect decrease dose ephedrine 0.1 0.07 mg/kg may clinically insignificant , investigator postulate prophylactic use small dose ephedrine may prevent propofol-induced hypotension induction anesthesia valve surgery minimal hemodynamic , ST segment , troponin I change . The aim present study investigate effect pre-induction administration 0.07 , 0.1 , 0.15 mg/kg ephedrine heart rate ( HR ) , mean arterial blood pressure ( MAP ) , central venous pulmonary artery occlusion pressure ( CVP PAOP , respectively ) , cardiac ( CI ) , stroke volume ( SVI ) , systemic pulmonary vascular resistance ( SVRI PVRI , respectively ) , leave right ventricular stroke work ( LVSWI RVSWI , respectively ) index , ST segment , cardiac troponin I ( cTnI ) change patient anesthetized propofol-fentanyl valve surgery .</brief_summary>
	<brief_title>Preoperative Ephedrine Attenuates Hemodynamic Responses Propofol During Valve Surgery : A Dose Dependent Study</brief_title>
	<detailed_description>One hundred fifty ASA III-IV patient age 18-55 year schedule elective valve surgery include randomize double blind placebo-controlled study author 's center obtain approval local ethical committee write informed consent participant . The sample size determine prior power analysis indicate 27 patient group would sufficiently large sample size adequate detect 20 % change SVRI value , type-I error 0.05 power approximately 85 % . We add 10 % patient account patient drop study . All operation perform surgeon . Participants allocate randomly five group ( n=30 ) receive saline [ group 1 ] ephedrine 0.07 , 0.1 0.15 mg/kg [ group 2 , 3 , 4 , respectively ] phenylephrine 1.5 ug/kg [ group 5 ] 1 min induction anesthesia . Patients document un-controlled hypertension , ischemic heart disease , leave ventricular ejection fraction le 45 % , peripheral vascular disease , thyrotoxicosis , neurological , hepatic , renal disease , pregnancy , re-do emergency surgery , allergy study medication , require preoperative inotropic , vasopressor mechanical circulatory ventilatory support , electrocardiograph ( ECG ) characteristic would interfere ST segment monitoring , include baseline ST segment depression , leave bundle-branch block , atrial fibrillation , leave ventricular hypertrophy , digitalis effect , QRS duration &gt; 0.12 , well pacemaker-dependent rhythm , exclude study . All routine medication except angiotensin-converting enzyme inhibitor continue morning operation . All patient premedicated 0.03 mg/kg IV midazolam fentanyl 1 µg/kg invasive instrumentation . All patient monitor pulse oximetry , non invasive blood pressure five lead electrocardiography ( lead II V5 ) ( Life Scope Monitor , BSM-4113 , Nihon Kohden Corp , Japan ) . Continuous ST segment trend electronically measure J-point + 60 m exclude T wave episode tachycardia . The tabulated graphic ST segment data review two investigator involve study blind patient 's group significant ischemic response . The late define reversible ST segment change baseline either ≥ 1 mV ST-segment depression ≥2 mV ST-segment elevation last least 1 minute . A radial artery catheter flow-directed balloon-tipped pulmonary artery catheter place local anesthesia induction . The final position pulmonary artery catheter tip confirm portable chest x- ray film pulmonary artery diastolic pressure &gt; PAOP . CI measure thermodilution use ice cold injectate . Five measurement perform , low high reading discard , mean reading record . Intravenous infusion 5-7mL/Kg 6 % Hydroxyethyl Starch 130/0.4 ( Voluven , Fresenius Kabi , Bad Hombourg , Germany ) give induction general anesthesia baseline PAOP le 10 mm Hg . End-tidal carbon dioxide monitor placement nasogastric tube , rectal nasopharyngeal temperature probe do induction anesthesia . Subjects allocate randomly four group draw sequentially number seal opaque envelope contain computer-generated randomization code . The subject receive intravenous injection 0.1 mL/kg study solution contain either saline 0.9 % solution [ group 1 ( n=30 ) ] , ephedrine 0.7 mg/mL [ group 2 ( n=30 ) ] , ephedrine 1 mg/mL [ group 3 ( n=30 ) ] ephedrine 1.5 mg/mL [ group 4 ( n=30 ) ] , phenylephrine 15 mcg/mL [ group 5 ( n=30 ) ] . All study solution inject 1 min 1 min induction anesthesia . The placebo ephedrine solution prepare identical syrinx label 'study drug ' local pharmacy department induction anesthesia . The anesthesia provider blind study solution involve study . All staff operate room unaware randomization code . Anesthesia induce fentanyl 5 µg/kg , propofol 2-2.5 mg/kg , cisatracurium 0.2 mg/kg give muscle relaxation . After endotracheal intubation , lung ventilate mixture oxygen air maintain arterial carbon dioxide tension 4.5-6 kPa . Anesthesia maintain continuous infusion propofol 4-6 mg/kg/ h , fentanyl 0.025 µg/kg/min , cisatracurium 1-3 µg/Kg/ min maintain suppression second twitch use train-of-four stimulation . All patient receive slow injection tranexamic acid 50 mg/kg initiation CPB . Target MAP HR within 20 % mean baseline value . Hypotension ( MAP ≤ 60 mm Hg ≥ 2-3 minute ) treat intravenous fluid ; reduction infusion rate propofol 50 % , bolus dos ephedrine 5 mg . Hypertension ( MAP ≥ 20 % mean baseline ≥ 2-3 minute ) treat increase infusion rate propofol 50 % , bolus dos labetalol 20 mg , nitroglycerin 0.05 mg. Tachycardia ≥20 % baseline value ≥1 minute treat modulation propofol infusion rate bolus esmolol 20 mg. Bradycardia ( HR ≤ 40/min ) treat atropine 0.5 mg . The cardiopulmonary bypass ( CPB ) line , oxygenator , venous reservoir prim . Heparin sodium 300 IU/kg give pericardiotomy achieve celite-activated clotting time become high 480 s. Standard CPB technique establish ascend aorta cannula bicaval venous cannulae . During CPB , non-pulsatile pump flow rate 2.4 L min/ m2 use twin roller pump hollow fiber membrane oxygenator , perfusion pressure 50-80 mmHg , arterial carbon dioxide tension 35-40 mmHg , unadjusted temperature ( α-stat ) , arterial oxygen tension 150-250 mmHg , moderate systemic hypothermia ( nasopharyngeal temperature 33-34°C ) maintain . Myocardial viability preserve topical hypothermia cold blood antegrade cardioplegia administer intermittently aortic root . Before separation CPB , patient rewarmed ( nasopharyngeal temperature 37°C , bladder temperature 36°C ) epinephrine nitroglycerine infusion use need CPB . Heparin neutralized discontinuation CPB protamine sulfate . After surgery propofol 1-2 mg/kg/ h use sedation ICU morphine 0.05 µg/kg use need analgesia . Propofol infusion discontinue ventilator weaning start patient awake cooperative , hemodynamically stable without high dos inotropic support , severe arrhythmia , body core temperature &gt; 35.5°C , bleed &lt; 100 mL/h , urine output &gt; 0.5 mL/kg/h , arterial oxygen tension &gt; 100 mm Hg oxygen concentration &lt; 0.5 . Primary outcome variable include change hemodynamic variable namely ; HR , MAP , CI , SVRI , LVSWI , ST segment change . Secondary outcome variable CVP , PAOP , RVSWI , troponin I change , need vasoactive drug . Anesthesia provider involve assessment patient . Other anesthesiologist blind study group operative room perform assessment . HR , MAP , CI , SVI , CVP , PAOP , SVRI , PVRI , LVSWI , RVSWI change record ( baseline ) , 5 min induction , 5 , 10 , 15 , 30 min endotracheal intubation ; 15 min sternotomy . The change hemodynamic data calculate percentage baseline measurement . The number total time intra-operative ischemic episode record group . Venous blood sample draw , 3 , 12 , 24 , 48 hour CPB measure cardiac troponin I . Blood sample centrifuge 3,000 rpm 10 min serum sample store at-20°C . Two specific monoclonal antibody use avoid cross-reactivity human skeletal muscle measurement cTnI . The upper reference limit cTnI control population 0.6 µg/L . The number patient receive rescue dos labetalol , ephedrine , atropine esmolol , time induction intubation ( I-T ) skin incision ( I-S ) major complication ( hypoxemia ( SaO2 &lt; 90 % ) , arrhythmias , respiratory failure , cardiovascular event ) record group . Data test normality use Kolmogorov-Smirnov test . Repeated-measures analysis variance use analysis serial change hemodynamic cTnI data different time administration study solution . Fisher exact test use categorical data . Repeated measure analysis variance ( ANOVA ) use continuous parametric variable difference correct post-hoc Bonferoni test . The Kruskal-Wallis one-way ANOVA perform intergroup comparison non-parametric value post hoc pairwise comparison do use Wilcoxon rank sum test . Univariate analyse preoperative risk factor , namely EuroSCORE frequency significant hypotension ST segment change propofol anesthesia perform . Univariate predictor examine stepwise manner multivariate logistic regression model , entry retention set significance level p &lt; 0.05 assess independent impact risk factor outcome . Data express mean ( SD ) , number ( % ) , median [ range ] . A value p &lt; 0.05 consider represent statistical significance .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>One hundred fifty ASA IIIIV patient age 1855 year schedule elective valve surgery Patients document uncontrolled hypertension ischemic heart disease leave ventricular ejection fraction le 45 % peripheral vascular disease thyrotoxicosis neurological hepatic renal disease pregnancy redo emergency surgery allergy study medication require preoperative inotropic , vasopressor mechanical circulatory ventilatory support electrocardiograph ( ECG ) characteristic would interfere ST segment monitoring , include baseline ST segment depression , leave bundlebranch block , atrial fibrillation , leave ventricular hypertrophy , digitalis effect , QRS duration &gt; 0.12 , well pacemakerdependent rhythm ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Ephedrine</keyword>
	<keyword>phenylephrine</keyword>
	<keyword>hypotension</keyword>
	<keyword>propofol</keyword>
	<keyword>anesthesia</keyword>
	<keyword>cardiac valve surgery</keyword>
</DOC>